Pharmafile Logo

Top 100 Creative Companies

- PMLiVE

AZ nabs US approval for new leukaemia drug Lumoxiti

Adds to firm's growing oncology franchise

- PMLiVE

New data keeps AbbVie’s star pipeline therapies on track

Data showed 56% of patients on risankizumab were symptom free after a year’s treatment

- PMLiVE

‘Streamlined’ medicines regulation promised in ‘No Deal’ Brexit scenario

UK would miss out on new EU clinical trial regulations

Gilead Sciences

Gilead targets hep B in half a billion dollar deal with Precision BioSciences

Biopharma looks to genome editing platform to discover hepatitis B cure

- PMLiVE

Saatchi and Saatchi Wellness London launch IVF campaign

The advertising agency targets fair access to IVF treatments

- PMLiVE

Boehringer bolts on another immuno-oncology company

Acquires ViraTherapeutics in a €210m takeover deal

PM Society Digital Awards – the power of together

Our chief executive, Emma Statham, writes about the value of awards and the power of together.

Four Agency Worldwide

- PMLiVE

Shire’s bleeding disorder drug approved in Europe

Veyvondi for patients with rare disease von Willebrand disease

Bristol Myers Squibb logo

BMS psoriasis drug hits the mark in phase II

Tyrosine kinase 2 (Tyk2) inhibitors could play major role

- PMLiVE

Seduce anyone in four simple steps

You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Page & Page Health

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links